0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query ark patent intelligence ceritinib patent extension data exclusivity expiry snapshot 50 countries.Your search for "" gave back 1532399 results.
CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors The present Competitive Intelligence Report about CD20 Antibodies - Rituximab...
Catalog:
La Merie Publishing
February 2014
Price: USD 401.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
Catalog:
CBR Pharma Insights
July 2015
Price: USD 2,995.00
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics...
Catalog:
CBR Pharma Insights
January 2019
Price: USD 2,995.00
As an extension of the intelligent medicine cabinet, the intelligent medicine rack is used to store the large infusion and heterogeneous drugs that...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The “Ceritinib Industry Forecast” looks at past sales and reviews total world Ceritinib sales in 2022, providing a comprehensive analysis by region...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global Ceritinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Ceritinib market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Parathyroid hormone/parathyroid hormone-related peptide receptor also known as parathyroid hormone 1 receptor (PTH1R) functions as a receptor for...
Catalog:
La Merie Publishing
October 2013
Price: USD 265.00
The present Competitive Intelligence Report about Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor...
Catalog:
La Merie Publishing
February 2014
Price: USD 413.00
VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors The present Competitive Intelligence Report about VEGF Antibodies –...
Catalog:
La Merie Publishing
February 2014
Price: USD 401.00
This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the...
Catalog:
La Merie Publishing
March 2015
Price: USD 346.00
U.S. (United States) pharmaceutical market is the largest pharmaceuticals market in the world and accounted for more than 40% global pharmaceuticals...
Catalog:
NAVADHI
March 2019
Price: USD 3,500.00
Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis provides a...
Catalog:
La Merie Publishing
February 2015
Price: USD 460.00
